MENDOTA HEIGHTS, Minnesota — BioDrain Medical, which makes a device that manages fluids gathered during surgical procedures, has raised $1.6 million, according to a filing with the Securities and Exchange Commission.
BioDrain is going public and is in its 30-day quiet period, so no one from the company would discuss the fund-raise. The company in April announced FDA approval of its Streamway surgical fluid disposal system, which plugs into an operating room’s existing plumbing to collect suctioned fluids and then dispose of them without handling.
BioDrain is a seven-year-old business with a product that takes on some giant competitors such as Cardinal Health and Stryker, which both have fluid-disposal products. BioDrain thinks its automated system dramatically cuts staff exposure to suctioned fluids, as well as time needed to dispose of them.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
There’s no final date for BioDrain’s public offering.
Related articles by Zemanta
- ClearCount Medical the latest Pittsburgh firm to count the cash (medcitynews.com)
- Minnesota’s DGIMed Ortho raising $4.5 million (medcitynews.com)
- Michigan dental device company Axenic raising $1 million (medcitynews.com)
